Advertisement

Standard and Novel Surgical Treatment in Cervical Cancer

  • Georgios AndroutsopoulosEmail author
  • Raj Naik
Chapter

Abstract

Cervical cancer represents a major clinical problem as it is globally the most common malignancy of the female reproductive system and usually affects young women. The surgical management of these patients could be either conservative or radical and depends on disease stage.

More specifically, conservative surgical management (cervical conization, radical trachelectomy) is mainly used in cervical cancer patients with early-stage disease and strong desire for fertility preservation. Likewise, standard surgical management (radical hysterectomy) is preferred in cervical cancer patients with early-stage disease, who have already completed their childbearing. Moreover, salvage surgical management (pelvic exenteration, laterally extended endopelvic resection) is indicated in patients with locally advanced, persistent, or recurrent cervical cancer, who have already been treated with radiotherapy or chemoradiotherapy.

In conclusion, the type and extent of surgical treatment in these patients should be carefully individualized according to disease stage, histologic subtype, fertility issues, and performance status.

Keywords

Cervical cancer Surgical treatment Cervical conization Radical trachelectomy Radical hysterectomy Pelvic exenteration Laterally extended endopelvic resection 

References

  1. 1.
    WHO. Estimated cancer incidence, mortality and prevalence worldwide in 2012. GLOBOCAN 2012.Google Scholar
  2. 2.
    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    NCCN. Clinical practice guidelines in oncology: cervical cancer. NCCN.org. 2017:1–83.Google Scholar
  4. 4.
    ESGO. Algorithms for management of cervical cancer. ESGO.org. 2010:1–8.Google Scholar
  5. 5.
    Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(Suppl 4):iv72–83.CrossRefGoogle Scholar
  6. 6.
    Chuang L, Temin S, Berek J. Management and care of women with invasive cervical cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline Summary. J Oncol Pract. 2016;12(7):693–6.CrossRefGoogle Scholar
  7. 7.
    Androutsopoulos G, Kotsopoulos I, Michail G, Decavalas G. Fertility sparing approach in young patients with early stage cervical cancer. Obstet Gynecol Int J. 2017;6(2):00197.CrossRefGoogle Scholar
  8. 8.
    Del Priore G. Cone biopsy. An atlas of gynecologic oncology: CRC Press; 2011. p. 68–70.Google Scholar
  9. 9.
    Naik R, Cross P, Nayar A, Mayadevi S, Lopes A, Godfrey K, et al. Conservative surgical management of small-volume stage IB1 cervical cancer. BJOG. 2007;114(8):958–63.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Biliatis I, Kucukmetin A, Patel A, Ratnavelu N, Cross P, Chattopadhyay S, et al. Small volume stage 1B1 cervical cancer: is radical surgery still necessary? Gynecol Oncol. 2012;126(1):73–7.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Androutsopoulos G, Kotsopoulos I, Korompelis P, Decavalas G. Does conservative surgical management of early stage cervical cancer represent a persistent dilemma in young patients? OA J Surg. 2017;3(3):555611.Google Scholar
  12. 12.
    Viswanathan A, Deavers M, Jhingran A, Ramirez P, Levenback C, Eifel P. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004;93(1):27–33.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Young R, Clement P. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology. 2002;41(3):185–207.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Lopes T, Spirtos N, Naik R, Monaghan J. Operations on the cervix. Bonney’s gynaecological surgery. Chichester: Wiley-Blackwell; 2010. p. 81–98.CrossRefGoogle Scholar
  15. 15.
    Miroshnichenko G, Parva M, Holtz D, Klemens J, Dunton C. Interpretability of excisional biopsies of the cervix: cone biopsy and loop excision. J Low Genit Tract Dis. 2009;13(1):10–2.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Fanning J, Padratzik J. Cold knife conization vs. LEEP. Are they the same procedure? J Reprod Med. 2002;47(1):33–5.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Kim M, Kim M, Kim J, Chung H, Park N, Song Y, et al. Loop electrosurgical excision procedure findings for identification of patients with early-stage cervical cancer suitable for less radical surgery. Int J Gynecol Cancer. 2012;22(7):1214–9.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Andikyan V, Khoury-Collado F, Denesopolis J, Park K, Hussein Y, Brown C, et al. Cervical conization and sentinel lymph node mapping in the treatment of stage I cervical cancer: is less enough? Int J Gynecol Cancer. 2014;24(1):113–7.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367(9509):489–98.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Wright J, NathavithArana R, Lewin S, Sun X, Deutsch I, Burke W, et al. Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access. Obstet Gynecol. 2010;115(3):585–90.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Ditto A, Martinelli F, Bogani G, Fischetti M, Di Donato V, Lorusso D, et al. Fertility-sparing surgery in early-stage cervical cancer patients: oncologic and reproductive outcomes. Int J Gynecol Cancer. 2015;25(3):493–7.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Haller H, Krasevic M, Mamula O, Brncic-Fischer A, Eminovic S, Manestar M. Treatment and outcome of stage Ia1 squamous cell carcinoma of the uterine cervix. Int J Gynaecol Obstet. 2011;113(1):72–5.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Raspagliesi F, Ditto A, Quattrone P, Solima E, Fontanelli R, Dousias V, et al. Prognostic factors in microinvasive cervical squamous cell cancer: long-term results. Int J Gynecol Cancer. 2005;15(1):88–93.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Nam K, Kwon J, Kim Y, Park Y. Pregnancy outcome after cervical conization: risk factors for preterm delivery and the efficacy of prophylactic cerclage. J Gynecol Oncol. 2010;21(4):225–9.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Dargent D, Brun J, Roy M, Mathevet P, Remy I. La trache’-lectomie e’largie (TE), une alternative a’ l’hyste’rectomie radicale dans le traitement des cancers infiltrants de’veloppe’s sur la face externe du col ute’rin. JOBGYN. 1994;2:285–92.Google Scholar
  27. 27.
    Dargent D, Martin X, Sacchetoni A, Mathevet P. Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer. 2000;88(8):1877–82.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Smith J, Boyle D, Corless D, Ungar L, Lawson A, Del Priore G, et al. Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma. Br J Obstet Gynaecol. 1997;104(10):1196–200.CrossRefGoogle Scholar
  29. 29.
    Schneider A, Erdemoglu E, Chiantera V, Reed N, Morice P, Rodolakis A, et al. Clinical recommendation radical trachelectomy for fertility preservation in patients with early-stage cervical cancer. Int J Gynecol Cancer. 2012;22(4):659–66.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Abu-Rustum N, Sonoda Y, Black D, Levine D, Chi D, Barakat R. Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature. Gynecol Oncol. 2006;103(3):807–13.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Peppercorn P, Jeyarajah A, Woolas R, Shepherd J, Oram D, Jacobs I, et al. Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experience. Radiology. 1999;212(2):395–9.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Balleyguier C, Sala E, Da Cunha T, Bergman A, Brkljacic B, Danza F, et al. Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol. 2011;21(5):1102–10.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Lakhman Y, Akin O, Park K, Sarasohn D, Zheng J, Goldman D, et al. Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. Radiology. 2013;269(1):149–58.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Diaz JP, Sonoda Y, Leitao M, Zivanovic O, Brown C, Chi D, et al. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecol Oncol. 2008;111(2):255–60.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Cao D, Yang J, Wu X, Chen Y, Li L, Liu K, et al. Comparisons of vaginal and abdominal radical trachelectomy for early-stage cervical cancer: preliminary results of a multi-center research in China. Br J Cancer. 2013;109(11):2778–82.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Chan K, Naik R. Advances in surgical treatment of cervical cancer. Womens Health (Lond). 2008;4(3):245–56.CrossRefGoogle Scholar
  37. 37.
    Ramirez P, Pareja R, Rendon G, Millan C, Frumovitz M, Schmeler K. Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol. 2014;132(1):254–9.CrossRefGoogle Scholar
  38. 38.
    Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P. Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol. 2016;17(6):e240–53.CrossRefGoogle Scholar
  39. 39.
    Hauerberg L, Hogdall C, Loft A, Ottosen C, Bjoern S, Mosgaard B, et al. Vaginal radical trachelectomy for early stage cervical cancer. Results of the Danish National Single Center Strategy. Gynecol Oncol. 2015;138(2):304–10.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Ungar L, Palfalvi L, Hogg R, Siklos P, Boyle D, Del Priore G, et al. Abdominal radical trachelectomy: a fertility-preserving option for women with early cervical cancer. BJOG. 2005;112(3):366–9.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Lopes T, Spirtos N, Naik R, Monaghan J. Cervical cancer. Bonney's gynaecological surgery. Chichester: Wiley-Blackwell; 2010. p. 192–215.CrossRefGoogle Scholar
  42. 42.
    Plante M, Gregoire J, Renaud M, Roy M. The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol. 2011;121(2):290–7.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Einstein M, Park K, Sonoda Y, Carter J, Chi D, Barakat R, et al. Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: a comparison of surgical and pathologic outcomes. Gynecol Oncol. 2009;112(1):73–7.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Kucukmetin A, Biliatis I, Ratnavelu N, Patel A, Cameron I, Ralte A, et al. Laparoscopic radical trachelectomy is an alternative to laparotomy with improved perioperative outcomes in patients with early-stage cervical cancer. Int J Gynecol Cancer. 2014;24(1):135–40.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Vieira M, Rendon G, Munsell M, Echeverri L, Frumovitz M, Schmeler K, et al. Radical trachelectomy in early-stage cervical cancer: a comparison of laparotomy and minimally invasive surgery. Gynecol Oncol. 2015;138(3):585–9.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Johansen G, Lonnerfors C, Falconer H, Persson J. Reproductive and oncologic outcome following robot-assisted laparoscopic radical trachelectomy for early stage cervical cancer. Gynecol Oncol. 2016;141(1):160–5.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Cibula D, Ungar L, Palfalvi L, Bino B, Kuzel D. Laparoscopic abdominal radical trachelectomy. Gynecol Oncol. 2005;97(2):707–9.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Ungar L, Palfalvi L, Boyle D, Del Priore G, Smith RJ. Radical abdominal trachelectomy. In: An atlas of gynecologic oncology: CRC Press; 2011. p. 97–104.Google Scholar
  49. 49.
    Wethington S, Sonoda Y, Park K, Alektiar K, Tew W, Chi DS, et al. Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters. Int J Gynecol Cancer. 2013;23(6):1092–8.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Plante M, Roy M. Radical vaginal trachelectomy. In: An atlas of gynecologic oncology: CRC Press; 2011. p. 88–96.Google Scholar
  51. 51.
    Lanowska M, Mangler M, Spek A, Grittner U, Hasenbein K, Chiantera V, et al. Radical vaginal trachelectomy (RVT) combined with laparoscopic lymphadenectomy: prospective study of 225 patients with early-stage cervical cancer. Int J Gynecol Cancer. 2011;21(8):1458–64.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Alexander-Sefre F, Chee N, Spencer C, Menon U, Shepherd J. Surgical morbidity associated with radical trachelectomy and radical hysterectomy. Gynecol Oncol. 2006;101(3):450–4.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Pareja R, Rendon G, Sanz-Lomana C, Monzon O, Ramirez P. Surgical, oncological, and obstetrical outcomes after abdominal radical trachelectomy – a systematic literature review. Gynecol Oncol. 2013;131(1):77–82.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Gien L, Covens A. Fertility-sparing options for early stage cervical cancer. Gynecol Oncol. 2010;117(2):350–7.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Okugawa K, Kobayashi H, Sonoda K, Kaneki E, Kawano Y, Hidaka N, et al. Oncologic and obstetric outcomes and complications during pregnancy after fertility-sparing abdominal trachelectomy for cervical cancer: a retrospective review. Int J Clin Oncol. 2017;22(2):340–6.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Lintner B, Saso S, Tarnai L, Novak Z, Palfalvi L, Del Priore G, et al. Use of abdominal radical trachelectomy to treat cervical cancer greater than 2 cm in diameter. Int J Gynecol Cancer. 2013;23(6):1065–70.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Speiser D, Mangler M, Kohler C, Hasenbein K, Hertel H, Chiantera V, et al. Fertility outcome after radical vaginal trachelectomy: a prospective study of 212 patients. Int J Gynecol Cancer. 2011;21(9):1635–9.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Kasuga Y, Nishio H, Miyakoshi K, Sato S, Sugiyama J, Matsumoto T, et al. Pregnancy outcomes after abdominal radical Trachelectomy for early-stage cervical Cancer: a 13-year experience in a single tertiary-care center. Int J Gynecol Cancer. 2016;26(1):163–8.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Boss E, van Golde R, Beerendonk C, Massuger L. Pregnancy after radical trachelectomy: a real option? Gynecol Oncol. 2005;99(3 Suppl 1):S152–6.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Wertheim E. Zur frag der radikaloperation beim uteruskrebs. Arch Gynakol. 1900;61:627.CrossRefGoogle Scholar
  61. 61.
    Dargent D, Mathevet P. Schauta's vaginal hysterectomy combined with laparoscopic lymphadenectomy. Baillieres Clin Obstet Gynaecol. 1995;9(4):691–705.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Boyle D. Radical abdominal hysterectomy. An atlas of gynecologic oncology: CRC Press, 2011:71–77.Google Scholar
  63. 63.
    Maneo A, Landoni F, Cormio G, Colombo A, Mangioni C. Radical hysterectomy for recurrent or persistent cervical cancer following radiation therapy. Int J Gynecol Cancer. 1999;9(4):295–301.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350(9077):535–40.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Keys H, Bundy B, Stehman F, Muderspach L, Chafe W, Suggs C 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154–61.CrossRefGoogle Scholar
  66. 66.
    Morris M, Eifel P, Lu J, Grigsby P, Levenback C, Stevens R, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340(15):1137–43.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Kokka F, Bryant A, Brockbank E, Powell M, Oram D. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database Syst Rev. 2015;(4):Cd010260.Google Scholar
  68. 68.
    Bradbury M, Founta C, Taylor W, Kucukmetin A, Naik R, Ang C. Pathological risk factors and outcomes in women with stage IB2 cervical cancer treated with primary radical surgery versus chemoradiotherapy. Int J Gynecol Cancer. 2015;25(8):1476–83.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Gaffney D, Erickson-Wittmann B, Jhingran A, Mayr N, Puthawala A, Moore D, et al. ACR appropriateness criteria(R) on advanced cervical Cancer expert panel on radiation oncology-gynecology. Int J Radiat Oncol Biol Phys. 2011;81(3):609–14.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Monk B, Tewari K, Koh W. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol. 2007;25(20):2952–65.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Benedetti-Panici P, Maneschi F, D'Andrea G, Cutillo G, Rabitti C, Congiu M, et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer. 2000;88(10):2267–74.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
  73. 73.
  74. 74.
    Landoni F, Maneo A, Cormio G, Perego P, Milani R, Caruso O, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80(1):3–12.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Marnitz S, Kohler C, Affonso R, Schneider A, Chiantera V, Tsounoda A, et al. Validity of laparoscopic staging to avoid adjuvant chemoradiation following radical surgery in patients with early cervical cancer. Oncology. 2012;83(6):346–53.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Kucukmetin A, Biliatis I, Naik R, Bryant A. Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer. Cochrane Database Syst Rev. 2013;(10):Cd006651.Google Scholar
  77. 77.
    Nam J, Park J, Kim D, Kim J, Kim Y, Kim Y. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study. Ann Oncol. 2012;23(4):903–11.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Wang Y, Deng L, Xu H, Zhang Y, Liang Z. Laparoscopy versus laparotomy for the management of early stage cervical cancer. BMC Cancer. 2015;15:928.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Jackson K, Das N, Naik R, Lopes A, Godfrey K, Hatem M, et al. Laparoscopically assisted radical vaginal hysterectomy vs. radical abdominal hysterectomy for cervical cancer: a match controlled study. Gynecol Oncol. 2004;95(3):655–61.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Querleu D, Morrow C. Classification of radical hysterectomy. Lancet Oncol. 2008;9(3):297–303.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Cibula D, Abu-Rustum N, Benedetti-Panici P, Kohler C, Raspagliesi F, Querleu D, et al. New classification system of radical hysterectomy: emphasis on a three-dimensional anatomic template for parametrial resection. Gynecol Oncol. 2011;122(2):264–8.PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Cormier B, Diaz J, Shih K, Sampson R, Sonoda Y, Park K, et al. Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer. Gynecol Oncol. 2011;122(2):275–80.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Lecuru F, Mathevet P, Querleu D, Leblanc E, Morice P, Darai E, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol. 2011;29(13):1686–91.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Cibula D, Abu-Rustum N, Dusek L, Slama J, Zikan M, Zaal A, et al. Bilateral ultrastaging of sentinel lymph node in cervical cancer: lowering the false-negative rate and improving the detection of micrometastasis. Gynecol Oncol. 2012;127(3):462–6.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Cibula D, Velechovska P, Slama J, Fischerova D, Pinkavova I, Pavlista D, et al. Late morbidity following nerve-sparing radical hysterectomy. Gynecol Oncol. 2010;116(3):506–11.CrossRefGoogle Scholar
  86. 86.
    Ditto A, Martinelli F, Hanozet F, Reato C, Solima E, Zanaboni F, et al. Class III NSRH: oncological outcome in 170 cervical cancer patients. Gynecol Oncol. 2010;119(2):192–7.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Sedlis A, Bundy B, Rotman M, Lentz S, Muderspach L, Zaino R. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol. 1999;73(2):177–83.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Monk B, Wang J, Im S, Stock R, Peters W 3rd, Liu P, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol. 2005;96(3):721–8.PubMedCrossRefPubMedCentralGoogle Scholar
  89. 89.
    Rotman M, Sedlis A, Piedmonte M, Bundy B, Lentz S, Muderspach L, et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65(1):169–76.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Peters W 3rd, Liu P, Barrett R 2nd, Stock R, Monk B, Berek J, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606–13.PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer. 1948;1(2):177–83.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Leveque J. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review. Eur J Surg Oncol. 2015;41(8):975–85.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Graves S, Seagle B, Strohl A, Shahabi S, Nieves-Neira W. Survival after pelvic exenteration for cervical cancer: a National Cancer Database study. Int J Gynecol Cancer. 2017;27(2):390–5.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Lopes T, Spirtos N, Naik R, Monaghan J. Exenterative surgery. In: Bonney’s gynaecological surgery: Wiley-Blackwell; 2010. p. 222–30.Google Scholar
  95. 95.
    Monaghan J. Central recurrent cervical cancer. In: An atlas of gynecologic oncology: CRC Press; 2011. p. 105–11.Google Scholar
  96. 96.
    Marnitz S, Dowdy S, Lanowska M, Schneider A, Podratz K, Kohler C. Exenterations 60 years after first description: results of a survey among US and German gynecologic oncology centers. Int J Gynecol Cancer. 2009;19(5):974–7.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Marnitz S, Kohler C, Muller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol. 2006;103(3):1023–30.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Yoo H, Lim M, Seo S, Kang S, Yoo C, Kim J, et al. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea. J Gynecol Oncol. 2012;23(4):242–50.PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Berek J, Howe C, Lagasse L, Hacker N. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol. 2005;99(1):153–9.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    Goldberg G, Sukumvanich P, Einstein M, Smith H, Anderson P, Fields A. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003). Gynecol Oncol. 2006;101(2):261–8.CrossRefGoogle Scholar
  101. 101.
    Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Fagotti A, et al. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. Int J Gynecol Cancer. 2014;24(1):156–64.PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Ungar L, Palfalvi L, Novak Z. Primary pelvic exenteration in cervical cancer patients. Gynecol Oncol. 2008;111(2 Suppl):S9–12.PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    Ang C, Bryant A, Barton D, Pomel C, Naik R. Exenterative surgery for recurrent gynaecological malignancies. Cochrane Database Syst Rev 2014(2):Cd010449.Google Scholar
  104. 104.
    Guimaraes G, Baiocchi G, Ferreira F, Kumagai L, Fallopa C, Aguiar S, et al. Palliative pelvic exenteration for patients with gynecological malignancies. Arch Gynecol Obstet. 2011;283(5):1107–12.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Magrina J, Stanhope C, Weaver A. Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol. 1997;64(1):130–5.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Katory M, McLean R, Paez E, Kucukmetin A, Naik R. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: a 9 year consecutive single-centre cohort study. Int J Surg. 2017;43:38–45.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Witjes A, Lebret T, Comperat E, Cowan N, De Santis M, Bruins H, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71(3):462–75.CrossRefGoogle Scholar
  108. 108.
    Lee R, Abol-Enein H, Artibani W, Bochner B, Dalbagni G, Daneshmand S, et al. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int. 2014;113(1):11–23.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Shah N, Ward K, Plaxe S, Saenz C, McHale M. Urinary diversions: a time to enrich surgical training? Gynecol Oncol. 2016;140(1):120–3.PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    Colombo R, Naspro R. Ileal conduit as the standard for urinary diversion after radical cystectomy for bladder cancer. Eur Urol Suppl. 2010;9(10):736–44.CrossRefGoogle Scholar
  111. 111.
    Davis N, Burke J, McDermott T, Flynn R, Manecksha R, Thornhill J. Bricker versus Wallace anastomosis: a meta-analysis of ureteroenteric stricture rates after ileal conduit urinary diversion. Can Urol Assoc J. 2015;9(5–6):E284–90.PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Bricker E. Bladder substitution after pelvic evisceration. Surg Clin North Am. 1950;30(5):1511–21.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Wallace D. Ureteric diversion using a conduit: a simplified technique. Br J Urol. 1966;38(5):522–7.PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Wallace D. Uretero-ileostomy. Br J Urol. 1970;42(5):529–34.PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Miller B, Morris M, Gershenson D, Levenback C, Burke T. Intestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957–1990. Gynecol Oncol. 1995;56(2):207–10.PubMedCrossRefPubMedCentralGoogle Scholar
  116. 116.
    Musters G, Bemelman W, Bosker R, Burger J, van Duijvendijk P, van Etten B, et al. Randomized controlled multicentre study comparing biological mesh closure of the pelvic floor with primary perineal wound closure after extralevator abdominoperineal resection for rectal cancer (BIOPEX-study). BMC Surg. 2014;14:58.PubMedPubMedCentralCrossRefGoogle Scholar
  117. 117.
    Morley G, Hopkins M, Lindenauer S, Roberts J. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol. 1989;74(6):934–43.PubMedPubMedCentralGoogle Scholar
  118. 118.
    Turns D. Psychosocial issues: pelvic exenterative surgery. J Surg Oncol. 2001;76(3):224–36.PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Wang C, Lai C, Huang H, Hong J, Chou H, Huang K, et al. Recurrent cervical carcinoma after primary radical surgery. Am J Obstet Gynecol. 1999;181(3):518–24.PubMedCrossRefPubMedCentralGoogle Scholar
  120. 120.
    Shingleton H, Soong S, Gelder M, Hatch K, Baker V, Austin J Jr. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol. 1989;73(6):1027–34.PubMedPubMedCentralGoogle Scholar
  121. 121.
    Benn T, Brooks R, Zhang Q, Powell M, Thaker P, Mutch D, et al. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol. 2011;122(1):14–8.PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Höckel M. Laterally extended endopelvic resection: surgical treatment of infrailiac pelvic wall recurrences of gynecologic malignancies. Am J Obstet Gynecol. 1999;180(2 Pt 1):306–12.PubMedCrossRefPubMedCentralGoogle Scholar
  123. 123.
    Höckel M. Laterally extended endopelvic resection. Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall. Gynecol Oncol. 2003;91(2):369–77.PubMedCrossRefPubMedCentralGoogle Scholar
  124. 124.
    Höckel M. Laterally extended endopelvic resection (LEER) – principles and practice. Gynecol Oncol. 2008;111(Suppl 2):S13–7.CrossRefGoogle Scholar
  125. 125.
    Höckel M, Hentschel B, Horn L. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis. Lancet Oncol. 2014;15(4):445–56.PubMedCrossRefPubMedCentralGoogle Scholar
  126. 126.
    Höckel M. Laterally extended endopelvic resection. In: An atlas of gynecologic oncology: CRC Press; 2011. p. 120–6.Google Scholar
  127. 127.
    Höckel M, Wolf B, Hentschel B, Horn L. Surgical treatment and histopathological assessment of advanced cervicovaginal carcinoma: a prospective study and retrospective analysis. Eur J Cancer. 2017;70:99–110.PubMedCrossRefPubMedCentralGoogle Scholar
  128. 128.
    Höckel M, Horn L, Einenkel J. (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy. Gynecol Oncol. 2012;127(2):297–302.PubMedCrossRefPubMedCentralGoogle Scholar
  129. 129.
    Höckel M. Long-term experience with (laterally) extended endopelvic resection (LEER) in relapsed pelvic malignancies. Curr Oncol Rep. 2015;17(3):435.PubMedCrossRefPubMedCentralGoogle Scholar
  130. 130.
    Höckel M, Sclenger K, Hamm H, Knapstein P, Hohenfellner R, Rosler H. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer. 1996;77(9):1918–33.PubMedCrossRefPubMedCentralGoogle Scholar
  131. 131.
    Höckel M, Knapstein P. The combined operative and radiotherapeutic treatment (CORT) of recurrent tumors infiltrating the pelvic wall: first experience with 18 patients. Gynecol Oncol. 1992;46(1):20–8.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Obstetrics and GynaecologyUniversity of PatrasRionGreece
  2. 2.Department of Gynaecology, Northern Gynaecological Oncology CentreQueen Elizabeth HospitalGatesheadUK

Personalised recommendations